Yiliang Li

Peking Union Medical College and Chinese Academy of Medical Sciences

H指数:16

被引数:1,309

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The STING-Inflammasome Axis: Coordinated Immune Regulation and Therapeutic Potential Across Diverse Diseases

STING-炎症小体轴：在多种疾病中的协同免疫调控与治疗潜力

Immunological Investigations

IF2.4

2026-05-060

PRE

Optimized CDK19 PET Tracers: Spirocyclic-Driven Design and Prostate Cancer Imaging

CDK19优化的PET示踪剂：杂环驱动设计及前列腺癌成像

Journal of Medicinal Chemistry

IF6.8

2025-07-180

PRE

Potential interactions between STING pathway and the complement system in immune regulation

STING通路与补体系统在免疫调节中的潜在相互作用

Expert Review of Clinical Immunology

IF3.7

2025-06-240

PRE

Ionizing radiation induces neurotoxicity in Xenopus laevis embryos through neuroactive ligand-receptor interaction pathway

ENVIRONMENTAL RESEARCH

IF7.7

2024-09-010

PRE

Design, synthesis, and evaluation of novel stilbene derivatives that degrade acidic nucleoplasmic DNA-binding protein 1 (And1) and synergize with PARP1 inhibitor in NSCLC cells

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2024-07-291

OAAI

Bazedoxifene analogs as potential WDHD1 degraders and antitumor agents: Synthesis, evaluation and molecular dynamics simulation studies

DRUG DEVELOPMENT RESEARCH

IF4.2

2024-02-051

PRE

SREBP inhibitors: an updated patent review for 2008-present

EXPERT OPINION ON THERAPEUTIC PATENTS

IF4.6

2024-01-084

PRE

Stachydrine represses the proliferation and enhances cell cycle arrest and apoptosis of breast cancer cells via PLA2G2A/DCN axis

CHEMICAL BIOLOGY & DRUG DESIGN

IF3.3

2024-01-015

PRE

PRMD: an integrated database for plant RNA modifications

NUCLEIC ACIDS RESEARCH

IF13.1

2023-10-131

OAAI

PET imaging of new target CDK19 in prostate cancer

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2023-06-067

PRE

HELIYON

IF3.6

2023-06-016

OAAI

Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study

JOURNAL OF NATURAL PRODUCTS

IF3.6

2022-05-027

PRE

Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury

新型PHD2/HDACs混合抑制剂对顺铂诱导的急性肾损伤的保护作用

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-02-015

PRE

Structure-based design, synthesis, and evaluation of inhibitors with high selectivity for PARP-1 over PARP-2

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-01-0127

PRE

Identification of potent SENP1 inhibitors that inactivate SENP1/JAK2/STAT signaling pathway and overcome platinum drug resistance in ovarian cancer

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2021-12-269

OAAI

MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway

BIOENGINEERED

IF4.2

2021-12-2437

OAAI

Discovery and characterization of potent And-1 inhibitors for cancer treatment

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2021-12-199

Does prior exposure to immune checkpoint inhibitors treatment affect incidence and mortality of COVID-19 among the cancer patients: The systematic review and meta-analysis

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2021-12-016

OAAI

Oral microbiota affects the efficacy and prognosis of radiotherapy for colorectal cancer in mouse models

口腔菌群对小鼠结直肠癌放疗疗效及预后的影响

CELL REPORTS

IF6.9

2021-10-0146

A supercritical carbon dioxide layer in the Hadean atmosphere for the origin of life?

SCIENCE BULLETIN

IF21.1

2021-06-012

PREAI

Yiliang Li

个人简介

教育背景

工作经历

荣誉奖项

研究方向